Caries
5
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
4
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
ViiV HealthcareNC - Durham
4 programs1
3
0 ppm FPhase 3
NaFPhase 3
Sodium Fluoride ToothpastePhase 3
Calcium sodium phosphosilicatePhase 2
Colorado TherapeuticsCO - Louisville
1 programOral Health Care Early Intervention ProjectN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MottSilver Diamine Fluoride
SolventumClinpro 5000
Colorado TherapeuticsOral Health Care Early Intervention Project
Clinical Trials (3)
Total enrollment: 1,305 patients across 3 trials
Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques
Start: Jan 2016Est. completion: Sep 202098 patients
Phase 3Completed
In-situ Evaluation of Anti-caries Technology
Start: Jun 2012Est. completion: Jul 201329 patients
N/ACompleted
Oral Health Care Early Intervention Project
Start: Nov 2008Est. completion: Apr 20111,178 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.